Their performance was compared with that of old adults without AMD, along with young adults with normal eyesight. All three groups were extremely accurate in complementing the items to the corresponding picture, with correct response rates of about 99 %. Related StoriesRXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmologyCharles Bonnet syndrome: an interview with Dr. Dominic ffytcheL-DOPA drug might delay or prevent age-related macular degenerationHowever, there were significant differences in the initial exploration phase –when individuals were visually discovering the scenes presented on the touch screen. Average exploration period was about four seconds for AMD patients, compared to three secs for older subjects with normal eyesight.The study will be halted early just because a predefined interim evaluation by the independent Data Monitoring Committee uncovered clear evidence of a clinically important decrease in stroke and systemic embolism in individuals with atrial fibrillation regarded intolerant of or unsuitable for supplement K antagonist therapy who received apixaban as compared to aspirin. This interim analysis demonstrated a satisfactory safety profile for apixaban compared to aspirin also.